Australië - Engels - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - phenoxymethylpenicillin potassium, quantity: 277.18 mg (equivalent: phenoxymethylpenicillin, qty 250 mg) - capsule, hard - excipient ingredients: magnesium stearate; gelatin; titanium dioxide; iron oxide red; sodium lauryl sulfate; purified water - treatment of mild to moderately severe infections due to penicillin senstivie staphylococci, pneumococci, gonococci and haemolytic stretococci infections. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recent streptococcal infections including the prevention of recurrence following rhematic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/pr congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. note oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or childbirth.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - phenoxymethylpenicillin potassium, quantity: 554.37 mg (equivalent: phenoxymethylpenicillin, qty 500 mg) - capsule, hard - excipient ingredients: magnesium stearate; gelatin; titanium dioxide; iron oxide red; sodium lauryl sulfate; purified water - treatment of mild to moderately severe infections due to penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic stretococci infections. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recent streptococcal infections including the prevention of recurrence following rhematic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/pr congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. note oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or childbirth.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sodium bicarbonate, quantity: 178.5 mg; potassium chloride, quantity: 46.6 mg; sodium chloride, quantity: 350.7 mg; macrogol 3350, quantity: 13.125 g - solution, powder for - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation, treatment of chronic constipation. molaxole is also effective in resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by physical examination of the abdomen and rectum.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - mesalazine, quantity: 250 mg - tablet, enteric coated - excipient ingredients: microcrystalline cellulose; povidone; sodium carbonate; purified talc; titanium dioxide; iron oxide red; colloidal anhydrous silica; calcium stearate; glycine; iron oxide yellow; methacrylic acid copolymer; macrogol 6000; triethyl citrate - indications as at 12 september 1990: treatment of acute inflammatory large bowel disease. maintenance therapy of crohns colitis and ulcerative colitis in patients sensitive to sulfasalazine.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - procaine benzylpenicillin, quantity: 1.5 g - injection, suspension - excipient ingredients: sodium citrate dihydrate; water for injections; polysorbate 80 - indications as at 18 february 2002: treatment of moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests and also by clinical response. infections which usually respond to adequate dosage are: group a streptococcal infections including upper respiratory tract infections, skin and skin structure infections and scarlet fever; pneumococcal infections of the respiratory tract; susceptible staphylococcal infections, most gonococcal infections, syphilis, fusospirochaetosis (vincent's gingivitis and pharyngitis). cilicaine syringe 1.5 must be administered by the intramuscular route only (see section 4.2 dose and method of administration).

Australië - Engels - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - amoxicillin trihydrate, quantity: 574 mg (equivalent: amoxicillin, qty 500 mg) - capsule, hard - excipient ingredients: magnesium stearate; titanium dioxide; gelatin; purified talc - indications as at 6 november 2003: cilamox is indicated for the treatment of infections due to susceptible strains of the sensitive organisms. gram-negative: h. influenzae, e coli, pr. mirabilis, and n. gonorrhoeae. gram-positive: streptococcus species, s. pneumoniae, non-penicllinase producing staphlococci and bacillus anthracis. note 1: cilamox may be useful in instituting therapy prior to bacteriology; however, bacteriological studies to determine the causative organisms and their sensitivity to cilamox should be performed. note 2: penicillins are now generally regarded only as adjunctive to some other established first-line antibiotic therapy in the treatment and post-exposure prophylaxis of anthrax, because of concerns of constitutive and inducible beta-lactamase in bacillus anthracis. if use of amoxycillin is contemplated, appropriate bacteriological studies must be performed by a reliable and established test method. amoxycillin may then be suitable if the specific b. anthracis strain has been shown definitively to be sensitive to penicillin/amaxycillin.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - amoxicillin trihydrate, quantity: 287 mg (equivalent: amoxicillin, qty 250 mg) - capsule, hard - excipient ingredients: magnesium stearate; gelatin; titanium dioxide; purified talc - indications as at 6 november 2003: cilamox is indicated for the treatment of infections due to susceptible strains of the sensitive organisms. gram-negative: h. influenzae, e coli, pr. mirabilis, and n. gonorrhoeae. gram-positive: streptococcus species, s. pneumoniae, non-penicllinase producing staphlococci and bacillus anthracis. note 1: cilamox may be useful in instituting therapy prior to bacteriology; however, bacteriological studies to determine the causative organisms and their sensitivity to cilamox should be performed. note 2: penicillins are now generally regarded only as adjunctive to some other established first-line antibiotic therapy in the treatment and post-exposure prophylaxis of anthrax, because of concerns of constitutive and inducible beta-lactamase in bacillus anthracis. if use of amoxycillin is contemplated, appropriate bacteriological studies must be performed by a reliable and established test method. amoxycillin may then be suitable if the specific b. anthracis strain has been shown definitively to be sensitive to penicillin/amaxycillin.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - nicorandil, quantity: 10 mg - tablet - excipient ingredients: pregelatinised maize starch; croscarmellose sodium; mannitol; stearic acid - for the treatment of chronic stable angina pectoris.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - nicorandil, quantity: 20 mg - tablet - excipient ingredients: stearic acid; pregelatinised maize starch; mannitol; croscarmellose sodium - for the treatment of chronic stable angina pectoris.

Australië - Engels - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - pancreatic extract, quantity: 601.2 mg/g (equivalent: protease, qty 2000 ph eur unit; equivalent: amylase, qty 36000 ph eur unit; equivalent: lipase, qty 50000 ph eur unit) - granules, enteric-coated - excipient ingredients: hypromellose phthalate; cetyl alcohol; dimeticone 1000; macrogol 4000; triethyl citrate - creon micro is indicated as pancreatic enzyme replacement in paediatric and adult patients with pancreatic exocrine insufficiency (pei). pancreatic exocrine insufficiency is often associated with, but not limited to: cystic fibrosis, chronic pancreatitis, pancreatic surgery, gastrointestinal bypass surgery (eg. bilroth ii gastroenterostomy), ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).